{"filings":[{"id":746316,"accession_number":"0001829126-26-005814","cik":2006815,"company_name":"Voyager Acquisition Corp./Cayman Islands","ticker":"VACH","form_type":"8-K","filed_at":"2026-05-29T20:01:18+00:00","items":["1.01","2.03","3.02","7.01","9.01"],"status":"ready","headline":"Voyager/Veraxa secure $27.5M senior secured notes and $50M share purchase agreement","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["$27.5M senior secured notes due Aug 2027, monthly amortization of $2.75M, with warrants to buy 2.39M shares at $11.50.","$50M share purchase agreement with Lincoln Park Capital for up to $50M over 24 months, at 97% of market price.","Financing supports closing of business combination with Voyager and advancement of BiTAC-TCE/ADC pipeline.","Notes are senior secured by all assets; warrants have 4-year term, beneficial ownership limitation of 4.99%.","PubCo controls timing/amount of share sales to Lincoln Park; no short selling by Lincoln Park."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.8,"calibrated_materiality_score":0.8,"market_cap_usd":333010000.0,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":111708,"accession_number":"0001829126-26-002460","cik":2006815,"company_name":"Voyager Acquisition Corp./Cayman Islands","ticker":"VACH","form_type":"8-K","filed_at":"2026-03-18T23:59:59+00:00","items":["5.07","7.01","8.01","9.01"],"status":"ready","headline":"Voyager Acquisition shareholders approve Veraxa Biotech deal; 99.67% of Class A shares redeemed","summary_kind":"llm","event_type":"m_and_a","confidence":"high","bullets":["Shareholders approved business combination with Veraxa Biotech AG at March 12, 2026 meeting.","25,217,315 Class A shares redeemed (~99.67%), leaving ~$885,556 in trust account.","After closing, combined company to trade on Nasdaq as VRXA.","Remaining 82,685 Class A shares will convert into Veraxa Biotech Holding AG shares.","Closing subject to Nasdaq listing approvals and other customary conditions."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"negative","materiality_score":0.85,"calibrated_materiality_score":0.85,"market_cap_usd":333010000.0,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":111707,"accession_number":"0001829126-26-001748","cik":2006815,"company_name":"Voyager Acquisition Corp./Cayman Islands","ticker":"VACH","form_type":"8-K","filed_at":"2026-02-27T23:59:59+00:00","items":["7.01","9.01"],"status":"ready","headline":"VERAXA shareholders approve merger with Voyager SPAC; CHF 223,400 capital increase","summary_kind":"llm","event_type":"m_and_a","confidence":"high","bullets":["Shareholders approved absorption merger of VERAXA into Veraxa Biotech Holding AG; combined entity to rename to Veraxa Biotech AG.","Approved ordinary capital increase of CHF 223,400 for shares to be issued to Voyager shareholders.","Christoph Antz remains CEO; closing subject to Voyager shareholder vote; Nasdaq ticker expected to be VRXA.","Business combination originally announced April 22, 2025; proxy statement/prospectus filed Feb 19, 2026."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.65,"calibrated_materiality_score":0.65,"market_cap_usd":333010000.0,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":111706,"accession_number":"0001829126-26-000900","cik":2006815,"company_name":"Voyager Acquisition Corp./Cayman Islands","ticker":"VACH","form_type":"8-K","filed_at":"2026-02-03T23:59:59+00:00","items":["1.01","9.01"],"status":"ready","headline":"Voyager Acquisition raises Veraxa merger consideration to $1.35B; sponsor to forfeit shares","summary_kind":"llm","event_type":"m_and_a","confidence":"high","bullets":["Aggregate merger consideration increased by $50M to $1,350,000,000.","Sponsor forfeits 200,000 SPAC Class B shares and 400,000 SPAC warrants for cancellation.","Veraxa waives charter restriction to allow removal of $5,000,001 net tangible asset requirement.","PubCo to issue 200,000 ordinary shares and 400,000 warrants to Veraxa shareholders at closing."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.65,"calibrated_materiality_score":0.65,"market_cap_usd":333010000.0,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":128337,"accession_number":"0001829126-25-008292","cik":2006815,"company_name":"Voyager Acquisition Corp./Cayman Islands","ticker":"VACH","form_type":"8-K","filed_at":"2025-10-21T23:59:59+00:00","items":["1.01","9.01"],"status":"ready","headline":"Voyager Acquisition extends Veraxa Biotech deal deadline to Aug 7, 2026; removes SPAC termination fee","summary_kind":"llm","event_type":"m_and_a","confidence":"high","bullets":["Amendment to Business Combination Agreement extends drop-dead date to August 7, 2026.","SPAC Termination Fee eliminated for terminations under Section 10.1(i) (failure to close by end date).","Termination fee of $12.5M remains payable if deal terminated due to Veraxa breach under Section 10.1(f).","Amendment signed October 18, 2025; filed on Form 8-K on October 21, 2025."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.5,"calibrated_materiality_score":0.5,"market_cap_usd":333010000.0,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":145143,"accession_number":"0001829126-25-007177","cik":2006815,"company_name":"Voyager Acquisition Corp./Cayman Islands","ticker":"VACH","form_type":"8-K","filed_at":"2025-09-05T23:59:59+00:00","items":["7.01","9.01"],"status":"ready","headline":"SPAC Voyager to combine with Veraxa Biotech at ~$1.5B enterprise value; close expected Q4 2025","summary_kind":"llm","event_type":"m_and_a","confidence":"high","bullets":["Pro forma combined enterprise value of ~$1.5B; Veraxa shareholders roll over 100% of equity.","Transaction funded by $253M SPAC trust cash and $25M PIPE; closing anticipated in Q4 2025.","Pro forma ownership: Veraxa 78.6%, SPAC public 15.9%, Sponsor 4.0%, PIPE investors 1.6%.","Combined company to trade on Nasdaq; tickers: VACHU (units), VACH (shares), VACHW (warrants)."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":333010000.0,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":145142,"accession_number":"0001829126-25-005092","cik":2006815,"company_name":"Voyager Acquisition Corp./Cayman Islands","ticker":"VACH","form_type":"8-K","filed_at":"2025-07-16T23:59:59+00:00","items":["1.01","9.01"],"status":"ready","headline":"Voyager Acquisition Corp. adds PubCo and Merger Sub as parties to existing business combination agreement","summary_kind":"llm","event_type":"m_and_a","confidence":"high","bullets":["PubCo (Veraxa Biotech Holding AG) and Merger Sub joined the April 22, 2025 BCA with Voyager and Veraxa Biotech AG, dated July 16, 2025.","Merger Sub will issue shares in exchange for SPAC assets; shares then contributed to PubCo.","Exhibit A confirms PubCo is wholly owned by Voyager Acquisition Sponsor Holdco LLC, Merger Sub by PubCo."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.4,"calibrated_materiality_score":0.4,"market_cap_usd":333010000.0,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":163540,"accession_number":"0001829126-25-002874","cik":2006815,"company_name":"Voyager Acquisition Corp./Cayman Islands","ticker":"VACH","form_type":"8-K","filed_at":"2025-04-23T23:59:59+00:00","items":["1.01","7.01","9.01"],"status":"ready","headline":"Voyager Acquisition Corp. to merge with Veraxa Biotech AG; expected Q4 2025 close","summary_kind":"llm","event_type":"m_and_a","confidence":"high","bullets":["SPAC will merge with Merger Sub, then Veraxa will merge into PubCo, a Swiss public company.","SPAC Class A and B shares convert one-for-one into PubCo Class A shares; warrants convert to PubCo warrants.","Company shareholders eligible for up to 5M PubCo Class A earnout shares over three fiscal years post-close.","Termination fee of $12.5M payable by Company to SPAC under certain termination scenarios.","Sponsor and certain Company shareholders entered into voting, support and lock-up agreements."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":333010000.0,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":214375,"accession_number":"0001829126-24-005604","cik":2006815,"company_name":"Voyager Acquisition Corp./Cayman Islands","ticker":"VACH","form_type":"8-K","filed_at":"2024-08-16T23:59:59+00:00","items":["8.01","9.01"],"status":"ready","headline":"Voyager Acquisition Corp. closes $253M IPO and $7.7M private placement","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Closed IPO of 25,300,000 units at $10.00 each, generating $253.0M in gross proceeds.","Private placement of 7,665,000 warrants at $1.00 each raised $7.665M; total proceeds $260.665M.","Net proceeds of $254.265M deposited into trust account, held for future business combination.","Transaction costs totaled $17.1M, including $4.4M cash underwriting fee and $12.045M deferred fee.","Balance sheet as of August 12, 2024 shows total assets of $255.1M and shareholders' deficit of $(11.2)M."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"market_cap_usd":333010000.0,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":214374,"accession_number":"0001829126-24-005510","cik":2006815,"company_name":"Voyager Acquisition Corp./Cayman Islands","ticker":"VACH","form_type":"8-K","filed_at":"2024-08-14T23:59:59+00:00","items":["1.01","3.02","8.01","9.01"],"status":"ready","headline":"Voyager Acquisition Corp. closes $253M IPO, including full over-allotment; units start trading on Nasdaq","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["25,300,000 units sold at $10/unit for gross proceeds of $253M; includes 3.3M over-allotment units.","Sponsor purchased 5,037,500 private warrants at $1 each; underwriters purchased 2,627,500 private warrants at $1 each.","Trust account funded with $260.665M from IPO and private placement proceeds, held by Continental Stock Transfer & Trust.","Each unit consists of one Class A ordinary share and one-half redeemable warrant; whole warrant exercisable at $11.50.","Blank-check company seeks business combination within 24 months; Cantor Fitzgerald led the offering."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.55,"calibrated_materiality_score":0.55,"market_cap_usd":333010000.0,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null}],"next_cursor":null}